Firefly Neuroscience (AIFF) Stock Price, News & Analysis

Company Overview

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Key Stats

• Today's Range: $2.79 to $2.91
• 50-Day Range: $2.67 to $3.37
• 52-Week Range: $1.86 to $17.20
• Volume: 263,029 shs
• Average Volume: 1.53 million shs
• Market Capitalization: $37.29 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AIFF Stock Analysis - Frequently Asked Questions

How have AIFF shares performed this year?

Firefly Neuroscience's stock was trading at $2.65 at the beginning of 2025. Since then, AIFF stock has increased by 9.4% and is now trading at $2.90.

How were Firefly Neuroscience's earnings last quarter?

Firefly Neuroscience, Inc. (NASDAQ:AIFF) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($1.30) earnings per share for the quarter. Firefly Neuroscience had a negative net margin of 1,052.34% and a negative trailing twelve-month return on equity of 954.56%.

When did Firefly Neuroscience's stock split?

Shares of Firefly Neuroscience reverse split on Tuesday, August 13th 2024.The 1-3 reverse split was announced on Friday, August 9th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Who are Firefly Neuroscience's major shareholders?

Top institutional investors of Firefly Neuroscience include Geode Capital Management LLC (0.94%).
View institutional ownership trends.

How do I buy shares of Firefly Neuroscience?

Shares of AIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Firefly Neuroscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Firefly Neuroscience investors own include Broadcom (AVGO), Paylocity (PCTY), Analog Devices (ADI), Advanced Micro Devices (AMD), ASML (ASML), Baidu (BIDU) and Bruker (BRKR).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 8/08/2025
• Next Earnings (Estimated): 8/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:AIFF
• Previous Symbol: NASDAQ:AIFF
• CIK: 803578
• Web: fireflyneuro.com
• Phone: (888) 237-6412
• Fax: 703-293-7979
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.94)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.46 million
• Net Margins: -1,052.34%
• Pretax Margin: -1,095.23%
• Return on Equity: -954.56%
• Return on Assets: -334.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.45
• Quick Ratio: 1.45

Sales & Book Value

• Annual Sales: $110 thousand
• Price / Sales: 339.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.05) per share
• Price / Book: -58.00

Miscellaneous

• Outstanding Shares: 12,860,000
• Free Float: 11,777,000
• Market Cap: $37.29 million
• Optionable: N/A
• Beta: 3.20